Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. UT Southwestern discusses how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.
Toral Patel, M.D. /
Michael Youssef, M.D.
July 12, 2024
